XML 27 R9.htm IDEA: XBRL DOCUMENT
v3.19.3

Condensed Consolidated Financial Statements Detail | 9 Months Ended
--- | ---
Sep. 30, 2019
Condensed Consolidated Financial Statements Detail [Abstract] |
Condensed Consolidated Financial Statements Detail | 3. Condensed Consolidated Financial Statements Details Long-term Equity Securities As of September 30, 2019 and December 31, 2018, long-term equity securities consisted of an investment in Rezolute’s common stock of $0.9 million and $0.4 million, respectively (see Note 4). During the three and nine months ended September 30, 2019 and 2018, the Company recognized a loss of $0.3 million and gains of $0.5 million, and losses of $0.2 million and $0.6 million, respectively, in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive income (loss) due to the change in fair value of its investment in Rezolute’s common stock. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands):
|  | September 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
Accrued legal and accounting fees |  | $ | 315 |  |  | $ | 396 |
Accrued restructuring |  |  | — |  |  |  | 1,361 |
Accrued incentive compensation |  |  | 294 |  |  |  | 152 |
Accrued payroll and other benefits |  |  | 282 |  |  |  | 155 |
Other |  |  | 209 |  |  |  | 318 |
Total |  | $ | 1,100 |  |  | $ | 2,382 |
Net Income (Loss) Per Share Available to Common Stockholders The following is a reconciliation of the numerator (net income or loss) and the denominator (number of shares) used in the calculation of basic and diluted net income (loss) per share available to common stockholders (in thousands):
| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
Numerator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) | $ | 3,178 |  |  | $ | (4,578 | ) |  | $ | 2,339 |  |  | $ | (10,331 | )
Less: Allocation of undistributed earnings to participating securities |  | (1,327 | ) |  |  | — |  |  |  | (977 | ) |  |  | — |
Net income (loss) available to common stockholders, basic |  | 1,851 |  |  |  | (4,578 | ) |  |  | 1,362 |  |  |  | (10,331 | )
Add: Adjustments to undistributed earnings allocated to participating securities |  | 60 |  |  |  | — |  |  |  | 41 |  |  |  | — |
Net income (loss) available to common stockholders, diluted | $ | 1,911 |  |  | $ | (4,578 | ) |  | $ | 1,403 |  |  | $ | (10,331 | )
Denominator |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average shares used in computing basic net income (loss) per share available to common stockholders |  | 8,731 |  |  |  | 8,386 |  |  |  | 8,721 |  |  |  | 8,354 |
Effect of dilutive stock options |  | 708 |  |  |  | — |  |  |  | 657 |  |  |  | — |
Effect of dilutive warrants |  | 2 |  |  |  | — |  |  |  | 1 |  |  |  | — |
Weighted average shares used in computing diluted net income (loss) per share available to common stockholders |  | 9,441 |  |  |  | 8,386 |  |  |  | 9,379 |  |  |  | 8,354 |
Potentially dilutive securities are excluded from the calculation of diluted net income (loss) per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share available to common stockholders (in thousands):
| Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
| 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
Convertible preferred stock |  | — |  |  |  | 5,003 |  |  |  | — |  |  |  | 5,003 |
Common stock options and RSUs |  | 893 |  |  |  | 1,644 |  |  |  | 926 |  |  |  | 1,638 |
Warrants for common stock |  | 15 |  |  |  | 24 |  |  |  | 15 |  |  |  | 21 |
Total |  | 908 |  |  |  | 6,671 |  |  |  | 941 |  |  |  | 6,662 |

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Condensed consolidated financial statements detail. + References No definition available. + Details
Name: | xoma_CondensedConsolidatedFinancialStatementsDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration